Cargando…
The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
The SARS-CoV-2 variants B.1.617.1 (Kappa) contain multiple mutations in the spike protein. However, the effect of B.1.617.1 lineage-related mutants on viral infectivity and inactivated-virus vaccine efficacy remains to be defined. We therefore constructed 12 B.1.617.1-related pseudoviruses and syste...
Autores principales: | Yang, Xinyi, Zhu, Yuqi, Xun, Jingna, Liu, Jun, Wen, Qing, Lin, Yixiao, Shen, Xiaoting, Chen, Jun, Yuan, Songhua, Zhao, Xiaying, Wang, Jing, Pan, Hanyu, Yang, Jinlong, Liang, Zhiming, Liang, Yue, Lin, Qinru, Liang, Huitong, Zhou, Chunyan, Jin, Li, Xie, Weijian, Liu, Jianping, Lu, Daru, Ying, Tianlei, Shen, Yinzhong, Zhang, Xiaoyan, Xu, Jianqing, Yin, Chunhua, Wang, Pengfei, Jiang, Shibo, Lu, Hongzhou, Zhu, Huanzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420027/ https://www.ncbi.nlm.nih.gov/pubmed/36062074 http://dx.doi.org/10.1016/j.isci.2022.105016 |
Ejemplares similares
-
Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
por: Zhu, Yuqi, et al.
Publicado: (2022) -
Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants
por: Xu, Xuesong, et al.
Publicado: (2022) -
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England
por: Paton, Robert S., et al.
Publicado: (2022) -
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
por: Grüne, Barbara, et al.
Publicado: (2022)